Education
About Us
Working with TipRanks
Follow Us
Immuron Limited (AU:IMC)
ASX:IMC
IMC Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.06 - AU$0.14
Previous CloseN/A
Volume128.40K
Average Volume (3M)93.04K
Market Cap
€15.76M
Enterprise ValueAU$10.41M
Total Cash (Recent Filing)AU$26.44M
Total Debt (Recent Filing)AU$93.52K
Price to Earnings (P/E)―
Beta1.11
Next Earnings
Aug 29, 2025Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding233,526,870
10 Day Avg. Volume104,272
30 Day Avg. Volume93,044
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)16.10
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-6.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Immuron Limited News
PremiumCompany Announcements
Immuron Limited Reports Revenue Growth Amid Increased Losses
PremiumCompany Announcements
Immuron Limited Issues New Ordinary Shares Complying with Legal Standards
PremiumCompany Announcements
Immuron Limited Applies for Quotation of New SecuritiesPremiumCompany Announcements
Immuron Limited Reports Strong Travelan® Sales Growth in December 2024---
Options Prices
Currently, No data available
---
Ownership Overview
0.26% Insiders
―
Mutual Funds
― Other Institutional Investors
99.74% Public Companies and
Individual Investors
IMC FAQ
What was Immuron Limited’s price range in the past 12 months?
Immuron Limited lowest share price was AU$0.06 and its highest was AU$0.14 in the past 12 months.
What is Immuron Limited’s market cap?
Immuron Limited’s market cap is €15.76M.
When is Immuron Limited’s upcoming earnings report date?
Immuron Limited’s upcoming earnings report date is Aug 29, 2025 which is in 149 days.
How were Immuron Limited’s earnings last quarter?
Immuron Limited released its earnings results on Feb 26, 2025. The company reported -AU$0.011 earnings per share for the quarter, missing the consensus estimate of AU$0 by -AU$0.011.
Is Immuron Limited overvalued?
According to Wall Street analysts Immuron Limited’s price is currently Overvalued.
Does Immuron Limited pay dividends?
Immuron Limited does not currently pay dividends.
What is Immuron Limited’s EPS estimate?
Immuron Limited’s EPS estimate is 0.
How many shares outstanding does Immuron Limited have?
Immuron Limited has 233,526,870 shares outstanding.
What happened to Immuron Limited’s price movement after its last earnings report?
Immuron Limited reported an EPS of -AU$0.011 in its last earnings report, missing expectations of AU$0. Following the earnings report the stock price went up 2.564%.
Which hedge fund is a major shareholder of Immuron Limited?
Currently, no hedge funds are holding shares in AU:IMC
---
Immuron Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:IMC Sentiment 93%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-52.54%
12-Months-Change
Fundamentals
Return on Equity
-52.70%
Trailing 12-Months
Asset Growth
-40.75%
Trailing 12-Months
Company Description
Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
---
Technical Analysis
Biotron Limited
―
Starpharma Holdings Limited
―
Telix Pharmaceuticals Ltd.
―
PYC Therapeutics Limited
―
---